Bone mineral density and hormonal status in men with systemic lupus erythematosus

Abstract

A loss in bone mass was reported in premenopausal systemic lupus erythematosus (SLE) women, but this problem has not been studied in SLE males. We evaluated bone mineral density (BMD) in SLE males and the relationship between prolactin (PRL) and testosterone with BMD. We also studied the controversial effect of steroid therapy on BMD in these patients. We measured BMD in the lumbar spine and at the hip in 20 SLE men (mean age 37 y) and in the controls (n = 40). We measured PRL and testosterone in serum and saliva. The mean dose of prednisone at the time of study was 11.6 mg; and cumulative dose was 17.6 g. No significative decrease in BMD was detected in SLE males vs controls; either in the lumbar spine (1.00 ± 0.1 vs 1.05 ± 0.1 g/cm²) or in the femoral neck (0.84 ± 0.1 vs 0.87 ± 0.1 g/cm²). No patient or control had osteoporosis or fractures. We did not find any relationship between BMD and cumulative dose and baseline dose of corticosteroids. The mean values of PRL and testosterone (serum and salivary) were in the normal range. We did not find any correlation between BMD, PRL and androgens. This study did not show a loss in bone mass in SLE men on corticosteroid therapy.

Keywords

systemic lupus erythematosus male bone mineral density prolactin testosterone.

Get full access to this article

View all access options for this article.

References

Jackson JA , Kleerekoper MD Osteoporosis in men: Diagnosis, pathophysiology, and prevention. Medicine 1990; 69: 137-152.

Slemenda CW et al. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117: 286-291.

Hannan MT , Felson DT , Anderson JJ Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res 1992; 7: 547-553.

Kalla AA , Fataar AB , Jessop SJ , Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus . Arthritis Rheum 1993; 36: 1726-1734.

Formiga F. et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 274-276.

Pons F. et al.. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995; 34: 742-746.

Dhillon VB et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: A preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 1990; 49:624-626.

Lavalle C. et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-272.

Folomeev M. et al. Prolactin levels in men with SLE and RA. J Rheumatol 1990 ; 17: 1569-1570.

10.

Greenspan SL , Neer RM , Ridgway EC , Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 104: 777-782.

11.

Jackson JA , Kleerekoper M. , Parfitt AM Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism . Ann Intern Med 1986; 105: 543-545.

12.

Klibanski A. et al. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinolo Metab 1988; 67: 124-130.

13.

Sequeira JF et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993; 2: 315-317.

14.

Navarro MA , Gòmez JM , Villabona C. , Bonnin MR Salivary testosterone: a good measure to reflect free testosterone . Arch Intern Med 1987; 177: 1189.

15.

Tan EM et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

16.

Steinbrocker O. , Traeger CH , Batterman RE Therpautic criteria in rheumatoid arthritis . JAMA 1947; 140: 659-667.

17.

Isenberg DA , Shoenfeld Y. , Schwartz RS Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus . Arthritis Rheum 1984; 27: 132-138.

18.

World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843. World Health Organisation: Geneva, 1994.

19.

Inman RD Immunologic sex differences and the female preponderance in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 849.

20.

Font J. et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 1992; 51: 1050-1052.

21.

Pistiner M. et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991 ; 21: 55-64.

22.

Ward MM , Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990 ; 17: 220-224.

23.

Seeman E. , Melto MJ III, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75: 977-983.

24.

Cummings SR , Kelsey JL , Nevitt MC , O'Dowd KJ Epidemiology of osteoporosis and osteoporotic fractures. Epidemiology Rev 1985; 7: 178-208.

25.

Crilly RG , Francis RM , Nordin Bec. Steroid hormones, ageing and bone. Clin Endocrinol Metab 1981; 10: 115-138.

26.

Dykman TR et al. Evaluation of factors associated with glucocorticoid induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985; 28: 361-368.

27.

Jackson JA et al. Bone histomorphometry in hypogonadism. Ann Intern Med 1986; 105: 543-545.

28.

Babini SM et al. Laxity and rupture of the patellar tendon in systemic lupus erythematosus: association with secondary hyperparathyroidism. J Rheumatol 1988; 15: 1162-1165.

29.

Navarro MA et al. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids. J Rheumatol 1995; 22: 2238-2240.

30.

Navarro MA et al. Salivary testosterone levels in women with systemic lupus erythematosus . Arthritis Rheum 1992; 35: 557-559.

31.

Greenspan SL , Oppenheim DS , Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989; 110: 526-531.

32.

Mateo L. et al. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995; 22: 1455-1460.